This trial is testing a new combination therapy for newly diagnosed glioblastoma (GBM). The safety and efficacy of the combination therapy of TTFields + SRS+ Temozolomide (TMZ) will be determined.
1 Primary · 3 Secondary · Reporting Duration: 30 months
1 Treatment Group
1 of 1
12 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic radiosurgery (SRS) · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What prior research has been done on the effectiveness of Stereotactic radiosurgery (SRS)?
"At present, 215 medical trials are underway exploring Stereotactic radiosurgery (SRS), with 23 of those in the third phase. While Seoul, Songpa is home to most investigations into this technique, there are 4777 other sites running studies regarding SRS across the globe." - Anonymous Online Contributor
Are any new participants eligible to join this research endeavor?
"Affirmative. Patients are currently being recruited for this clinical trial, details of which were initially posted on the 21st of May 2021 and recently updated on August 17th 2022." - Anonymous Online Contributor
To what maladies has Stereotactic radiosurgery (SRS) been clinically demonstrated to be efficacious?
"When dealing with nitrosourea treatment, advance directives and refractory advanced mycosis fungoides, Stereotactic Radiosurgery (SRS) can be employed as an efficacious therapeutic approach." - Anonymous Online Contributor
Has the government approved of Stereotactic Radiosurgery (SRS) for public use?
"SRS is still in its early stages of research, so it has been assigned a score of 1. This reflects the limited evidence available on this treatment's safety and efficacy." - Anonymous Online Contributor
What is the scale of enrollment for this research initiative?
"Affirmative. The clinical trial is still recruiting, as indicated on its page hosted on clinicaltrials.gov. It was initially posted on May 21st 2021 and the last update was August 17th 2022; 12 volunteers are being sought out from a single medical centre." - Anonymous Online Contributor
Is this research endeavor pioneering in its approach?
"Globally, there are 36 countries with 940 cities encompassing 215 active clinical trials regarding Stereotactic Radiosurgery (SRS). The first trial of its kind was conducted in 2002 by Schering-Plough. This study featured 60 patients and achieved Phase 2 drug approval. Since then, 315 more studies have been completed." - Anonymous Online Contributor